Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01597986 · ClinicalTrials.gov registry record · Phase 1
Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone
A Phase 1 study, sponsored by Astellas Pharma Global Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01597986 is a Phase 1 study that has completed, run by Astellas Pharma Global Development. The registered enrollment target is 24 participants.
The verdict
NCT01597986, a Phase 1 study, has completed, sponsored by Astellas Pharma Global Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics (PK) of a single dose of contraceptive in healthy post-menopausal women.
Interventions
- DRUG isavuconazole
- DRUG Oral Contraceptive (ethinyl estradiol / norethindrone)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01597986
The ClinicalTrials.gov registry entry for NCT01597986 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma Global Development, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which isavuconazole is the first listed.
NCT01597986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01597986 about?
NCT01597986 is a clinical study titled "Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone". The purpose of this study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics (PK) of a single dose of contraceptive in healthy post-menopausal women.
What is the current status of trial NCT01597986?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2012-04. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01597986?
The interventions under investigation include: isavuconazole (DRUG), Oral Contraceptive (ethinyl estradiol / norethindrone) (DRUG).
Who is sponsoring clinical trial NCT01597986?
This trial is sponsored by Astellas Pharma Global Development, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.